Alternatives to Recursion
30 tools that compete with or replace Recursion. Ranked by direct product-type match — not generic category overlap.
Why people look for alternatives to Recursion
The complaints that come up most often in public discussion — reviews, forums and community threads. Not our opinion, and not the vendor's marketing.
- Highly complex platform requires advanced technical expertise to use
- Proprietary algorithms and data limit external validation and trust
- Clinical success still unproven; most programs in early phases
- High cost likely restricts access to well-funded organizations
Drawn from 68 mentions across 4 sources · researched Jul 31, 2026.
In fairness: users also consistently praise massive dataset integration (50+ petabytes) for deep biological insights, and automated wet lab enables millions of experiments weekly, accelerating discovery. A complaint list is not a verdict — see the full picture on the Recursion page.
Recursion Pharmaceuticals
AI-native drug discovery platform turning 50+ PB of cellular imaging data into clinical-stage therapies
Nimbus Therapeutics
Highly selective small-molecule drug discovery for oncology, immunology, and metabolic diseases.
Insilico Medicine
End-to-end generative AI drug discovery platform from target ID to clinical trials, validated by a Phase III pipeline.
Verge Genomics
All-in-human AI foundation models for precision neurology and CNS drug discovery
Schrodinger
Physics-based molecular discovery platform for drug and materials design
BenevolentAI
AI drug discovery knowledge graph for target identification and drug repurposing.
Exscientia
AI-driven drug discovery platform combining 50+ PB of proprietary data with automated wet labs to design and validate optimized molecules.
SciSpace BioMed Agent
AI co-scientist for biomedical research: multi-omics, drug discovery, and lab protocol reasoning
Algen Biotechnologies
AI-driven CRISPR platform revealing causal disease-driving RNA pathways for immunology and oncology drug discovery
Atlas Discovery
AI foundation models predicting patient drug response to de-risk clinical trials
Haplotype Labs
SaaS platform that reduces sequencing costs 50-90% with polygenic risk modeling.
Exin Therapeutics
AI target discovery platform for neurotherapeutics across disorders
Isomorphic Labs
AI-native drug discovery partner building on AlphaFold for pharma R&D.
Flatiron Health
Oncology real-world evidence platform turning patient data into AI-powered insights for cancer research and care.
Iambic Therapeutics
AI-native biotech accelerating small-molecule drug discovery from design to clinic
Frequently asked questions
What are the best alternatives to Recursion?
We currently list 30 alternatives to Recursion: Iktos, Recursion Pharmaceuticals, Evotec, Nimbus Therapeutics, Insilico Medicine. Each is ranked by direct product-type match rather than generic category overlap.
How do you choose which Recursion alternatives to show?
Alternatives are ranked by direct product-type match — tools that do the same job — not by shared category tags. Every listed tool is independently re-verified on a continuous cycle.